Both David Wichmann, UnitedHealth Group's CEO, and Stephen Hemsley, its former CEO and executive chairman, made over $50 million in salary, bonus and stock option compensation.

UnitedHealth Group Inc. said its current president, David S. Wichmann, will next month succeed Stephen J. Hemsley as chief executive, a widely expected transition at the top of the nation's ...

David Wichmann earned $42.1 million in compensation during his final year as CEO of UnitedHealth Group, one of the 10 largest publicly traded companies in the United States by revenue.

When UnitedHealth Group CEO David Wichmann fully exits the company next month, he'll leave with a nice parting gift: two years' salary and bonuses. In a Securities and Exchange Commission filing ...

UnitedHealth Group has picked company President David Wichmann to replace CEO Stephen Hemsley in a long-planned transition that Wall Street greeted with polite applause. The nation’s largest ...

David Wichmann, president of Minnetonka, Minn.-based UnitedHealth Group, will become CEO of the company Sept. 1 after Stephen Hemsley leaves the position. Here are three things to know. 1. Mr ...

UnitedHealth Group Inc.UNH-0.54%decrease; red down pointing triangle Chief Executive Officer David Wichmann retired from the health-care giant after 40 months in the role, an abrupt move that came ...

David Wichmann purchased 20,000 shares of UnitedHealth on May 3 for a total price of about $4.6 million. Related Articles UnitedHealth CEO's pay rose to $18 million in 2018 ...

Wichmann also weighed in on the use of point-of-sale drug rebates and his support for universal healthcare. UnitedHealth expects 150M members to be in value-based programs by 2025 | Fierce ...

UnitedHealth Group Incorporated (NYSE:UNH) Q4 2019 Earnings Conference Call January 15, 2020 8:45 AM ETCompany Participants. David Wichmann - Chief Executive Officer Andrew Witty - President and ...

228 Views Program ID: 470210-1 Category: White House Event Format: Remarks Location: Roosevelt Room, White House, Washington, District of Columbia, United States ...

David Wichmann. And one of the things we did was, as part of all, is we created a – leveraging that swabbing testing capability, so it allows for self-administration in a clinical setting.